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Analysis of Myc Bound Loci Identified by CpG
Island Arrays Shows that Max Is Essential
for Myc-Dependent Repression
upon Myc [2, 3]. To evaluate if Myc bound to the regula-
tory regions of these genes, chromatin immunoprecipi-
tation (ChIP) assays were conducted by using an anti-
c-Myc antibody as described previously [4]. Myc binding
to the 5 regulatory region of a known activated gene
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Madison, Wisconsin 53706 Interestingly, the Myc-dependent targets cloned in our
expression array, originally identified in a rat fibroblast
system, have been verified here as direct Myc targets
in a human myelogenous leukemia cell system. TheseSummary
data suggests that at least a subset of bona fide Myc
target genes will be regulated in a species- and cell type-The c-myc proto-oncogene encodes a transcription
independent manner and reinforce that ChIP analysis isfactor, c-Myc, which is deregulated and/or overex-
a powerful approach to definitively identify genes boundpressed in many human cancers. Despite c-Myc’s im-
portance, the identity of Myc-regulated genes and the by Myc.
mechanism by which Myc regulates these genes re-
main unclear. By combining chromatin immunoprecip-
itation with CpG island arrays, we identified 177 human Identifying Genomic Loci Bound by c-Myc
genomic loci that are bound by Myc in vivo. Analyzing in HL60 Cells
a cohort of known and novel Myc target genes showed Binding by Myc to the 5 regulatory region of a gene
that Myc-associated protein X, Max, also bound to within native chromatin provides compelling evidence
these regulatory regions. Indeed, Max is bound to that the gene is a direct target of Myc regulation. To
these loci in the presence or absence of Myc. The determine the regions of the human genome bound by
Myc:Max interaction is essential for Myc-dependent Myc, we probed a microarray spotted with 7776 CpG
transcriptional activation; however, we show that Max island clones, CG-rich DNA associated with 5 gene
bound targets also include Myc-repressed genes. regulatory regions, with Cy5-labeled chromatin isolated
Moreover, we show that the interaction between Myc by ChIP from exponentially growing HL60 cells by using
and Max is essential for gene repression to occur. an anti-c-Myc antibody or no antibody as a control [8].
Taken together, the identification and analysis of Myc This approach yielded 235 clones that had a 3-fold
bound target genes supports a model whereby Max normalized intensity in the anti-c-Myc immunoprecipi-
plays an essential and universal role in the mechanism tate as compared with the no antibody control in two
of Myc-dependent transcriptional regulation. independent experiments. After sequencing each clone,
we determined the genomic location for 209 of 235
Results and Discussion clones by BLAST searching the human genome (http://
www.ncbi.nlm.nih.gov/BLAST/). This analysis indicated
c-Myc Binds to the Regulatory Regions of Both that the CpG island clones corresponded to 177 unique
Activated and Repressed Gene Targets genomic loci, and the majority of these loci were located
Delineating the pathway from Myc gene regulation to within promoter regions, as assessed by their proximity
cellular functional changes has been hampered by the to the 5 end of the genes. A total of 107 of 177 loci are
limited number of bona fide Myc-regulated genes identi- associated with genes of known or inferred function (see
fied. While expression arrays have shown many genes Figure S1 in the Supplemental Data available with this
with altered expression when Myc is activated, few have article online). Importantly, the loci include known Myc-
been confirmed as direct Myc targets [1]. We recently activated (ddx18) and -repressed (c-myc) genes as well
used a cDNA microarray, followed by extensive analy- as several novel Myc target genes [9, 10].
ses, to identify genes whose regulation is dependent To validate that the loci identified were bound by Myc,
we performed conventional ChIP assays in HL60 cells.
As ChIP controls, Myc is shown to bind the 5 regulatory*Correspondence: lpenn@uhnres.utoronto.ca
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Figure 1. Myc Binds to Activated and Repressed Genes in HL60
Cells
ChIP assays with anti-c-Myc antibody (N-262, Santa Cruz) (lane 1)
or no antibody (lane 2) from logarithmically growing human HL60
Figure 2. Conventional ChIP Analysis Confirms that Myc Binds tocells were performed as described. Additional control reactions in-
the Novel Loci Identified by the Combined ChIP-CpG Island Microar-clude a no template mock IP (lane 3) and a 1, 1/2, and 1/4
ray Screentitration of input chromatin (lanes 4–6). DNA was PCR amplified by
ChIP assays with anti-c-Myc antibody (lane 1) or no antibody (laneusing primers designed against the regulatory regions indicated.
2) from logarithmically growing human HL60 cells. Additional controlThis includes an activated gene (cad) and an E box on chromosome
reactions include a 1, 1/2, and 1/4 titration of input chromatin22 (chrm22 E box) that serve as a positive and negative control,
(lanes 3–5) and a no template mock IP (lane 6). DNA was PCRrespectively, for binding by Myc, as well as Myc-activated and
amplified by using primers designed against a positive control (cad),-repressed genes previously identified as downstream of Myc by
negative control (chrm22 E box), and the sequences of ten randomlycDNA expression array analysis. Sequences for ChIP-PCR primers
selected positive clones. Two negative clones that had hybridizationare available upon request.
ratios 3-fold were randomly selected and are also shown. The
shaded bars to the right represent the fold binding observed on
each of two independent microarray hybridizations (I and II) for eachregion of cad, but not chrm22 E box (Figure 2). PCR
clone.primers were designed against the DNA sequence of 15
randomly selected positive clones, potentially repre-
senting Myc bound loci, as well as 2 negative clones,
The genes identified fall into broad functional catego-which did not specifically hybridize with a Myc-specific
ries and reinforce the notion that Myc regulates a wideChIP probe. All 15 positive clones were verified as being
variety of cellular activities (Figure S1). Interestingly,bound by Myc in growing, intact cells (Figures 2 and
groups of genes thought to participate in similar func-3A). By contrast, the two negative controls were not
tions have also been identified. For example, in additionbound by Myc (Figure 2). Thus, the combined ChIP and
to the RNA helicase, dead-box protein ddx18, thisCpG island microarray approach generated a high signal
screen reveals that ddx11 is also Myc bound. In addition,to noise ratio and efficiently identified Myc bound loci.
a cohort of 20 genes whose regulatory region is boundTo evaluate if the loci identified represented genes
by Myc as well as E2F, another potent regulator of cellwhose expression was regulated by Myc, reverse tran-
cycle progression and apoptosis, has been identifiedscriptase (RT)-PCR was used to assess gene expression
(Figure S1, footnote *) [8, 11]. An unexpected observa-in logarithmically growing (LOG) HL60 cells as well as
tion is the large number of bidirectional regulatory re-in cells triggered to differentiate by DMSO treatment
gions that are bound by Myc. This work reveals that the(DMSO), conditions in which endogeneous Myc protein
genes upstream and downstream of these regulatorylevels are high and low, respectively (data not shown).
regions can be coregulated by Myc. For example, bothRT-PCR analysis showed that the Myc bound loci corre-
hnrpa2b1 and cbx3 are activated by Myc, whereas thespond to targets that are Myc repressed (dleu1, dleu2,
putative tumor suppressors dleu1 and dleu2 are re-d1s155e, and dkfzp586c1924) and Myc activated (ube2c
pressed by Myc. Indeed, a number of loci associatedand mthfd1) (Figure 3B). Moreover, at least 34 additional
with leukemogenesis have also been identified in thisclones bound by Myc have been identified as being Myc
screen by using myelogenous leukemia-derived HL60regulated by one or more of the recent expression array
cells (dleu1, dleu2, meis1, meis2, and loc136319). Identi-analyses (Figure S1, footnote 2) (http://www.myc-cancer-
fying Myc bound loci has revealed many target genesgene.org/; O’Connell and Sedivy, personal communica-
that will be valuable reagents to explore the biologicaltion). While these analyses are not exhaustive, the re-
activities and mechanism of gene regulation by Myc.sults strongly suggest that these Myc bound targets
warrant further study at an individual level of their regula-
tion in response to Myc and their role in Myc biology. Max Is Present at Human Genomic
Loci Bound by MycTaken together, these analyses suggest the Myc bound
loci identified in this screen correspond to genes whose To explore how Myc regulates transcription, we directly
assessed the role of Max in the organization and regula-expression is indeed Myc regulated.
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sion. Moreover, the role of Max in the mechanism of
Myc-dependent repression remains largely unexplored.
To assess if Max could bind to all or a subset of the
novel Myc bound target genes, we performed anti-Max
ChIPs in exponentially growing HL60 cells. Strikingly,
Max bound to all genomic loci to which Myc was also
bound. This included genes that were bound and acti-
vated in response to Myc (mthfd1 and ube2c) and, im-
portantly, also genes that were bound and repressed
by Myc (dleu1, dleu2, d1s155e, dkfzp586c1924, fads2,
and n-pac) (Figures 3A and 3C). Indeed, we have also
performed ChIPs on the 21 genes described in Figures
1 and 2 and have not observed a single locus, including
14 known and novel Myc-repressed genes such as
gadd45a and cdkn2b, at which Myc is bound in the
absence of Max (Figures 3A and 3C; data not shown) [6,
20, 21]. Further analysis in HL60 cells under proliferating
(LOG) and differentiated (DMSO) conditions shows that
Myc binding to target genes is proportional to the level
of Myc protein in the cells (Figure 3C; data not shown).Figure 3. Max Binds to Myc Bound Genes before and after Myc
Max can bind, either alone or in combination with otherProtein Recruitment
Max binding proteins, to Myc-activated genes prior to(A) ChIP assays with anti-c-Myc (lane 1), anti-Max (C-124, Santa
Myc binding and may specify which genes are activatedCruz) (lane 2), or no antibody (lane 3) from logarithmically growing
HL60 cells. Additional control reactions include a 1, 1/2, and by Myc. Consistent with this model, we show that Max
1/4 titration of input chromatin (lanes 4–6) and a no template mock binds to the 5 regulatory region of apex, a Myc-acti-
IP (lane 7). gadd45a (shown at top) is a known Myc-repressed gene. vated gene, in LOG- and DMSO-treated cells (Figure 3C).
Below are five randomly selected positive clones (dleu1/2, d1s155e, Interestingly, Max also binds to Myc repressed genes
dkfzp586c1924, ube2c, and mthfd1), which were amplified by PCR
(fads2, n-pac, dkfzp586c1924, and cdkn2b) in a mannerby using primers designed against each locus. The shaded bars
that is independent of Myc protein levels or the degree(to their right) represent the fold binding observed on each of two
to which Myc is bound (Figure 3C). Neither Myc nor Maxindependent microarray hybridizations (I and II) for each clone.
(B) mRNA expression of genes whose regulatory regions are bound bound to the negative control region, chrm22 E box.
by Myc, as assessed by reverse transcriptase (RT)-PCR in logarith-
mically growing (lanes 1 and 3) and DMSO-treated (lanes 2 and 4) Max Binds to Repressed Genes
HL60 cells. A set of cDNA amplified under no RT conditions (lanes Independently of Myc
3 and 4) are included as controls to evaluate genomic DNA contami-
To investigate if Max could bind to regulatory regionsnation. Sequences for RT-PCR primers are available upon request.
of Myc-repressed genes in the absence of Myc protein,An asterisk indicates that the mRNA expression of dleu1 and dleu2,
we performed ChIP assays in subconfluent, asynchro-referred to as dleu1/2, was similarly regulated; thus, a representative
panel is shown. Genes that are repressed (R) or activated (A) by nous Rat-1c-myc/ cells [2]. We show Myc can bind to
c-myc expression are indicated. the regulatory regions of repressed genes (c-myc, tde1,
(C) ChIP assays with anti-c-Myc (lanes 1, 6, and 11), anti-Max (lanes and gadd45a) in Rat-1c-myc/ cells that ectopically ex-
2, 7, and 12), or no antibody (lanes 3, 8, and 13) from LOG- and press Myc, but not in the vector only control (Figure 4A).
DMSO-treated HL60 cells. Additional control reactions include a no
By contrast, Max binds to each of these 5 regulatorytemplate mock IP (lanes 4, 9, and 14) and 1 input chromatin to
regions in the c-myc null cells infected with either controlcontrol for the PCR reaction (lanes 5, 10, and 15). DNA was PCR
retrovirus or retrovirus carrying and expressing humanamplified by using primers designed against Myc-activated (apex)
and Myc-repressed (cdkn2b, d1s155e, dkfp586c1924, fads2, and c-myc (Figure 4A). Neither Myc nor Max bound to the
n-pac) genes, as well as a negative control (chrm22 E box). negative control region, glucokinase (gck) [17]. These
data show that Max binding to repressed genes can
occur in the absence of Myc protein. We also have
tion of Myc target genes. Myc and Max interact through observed this binding pattern at cad, a Myc-activated
their helix-loop-helix/leucine zippers, and this interac- gene, and this pattern is reminiscent of previous obser-
tion is essential for Myc to activate transcription as well vations with another Myc-activated target, cyclin D2
as to drive all its key biological activities tested to date [5, 18]. Determining how Max binds to loci, that do and
[12, 13]. Interaction enables Myc:Max heterodimers to do not contain E boxes, is an important question that
bind E box elements, CAC(A/G)TG, and activate tran- we are investigating. Interestingly, none of the cofactors
scription by at least two mechanisms: recruitment of that we have analyzed thus far appears to be the com-
histone acetyltransferase (HAT) or PTEFb complexes mon denominator at all Myc-repressed promoters
[5, 14–18]. By contrast, recent data suggest that Myc (D.Y.L.M. and L.Z.P., in preparation). Taken together,
represses transcription by binding to and inhibiting acti- we show that Max is bound to both Myc-activated and
vators at the core promoter region of target genes. For -repressed gene targets prior to Myc expression and
example, Myc can bind Miz-1 and block the transcrip- recruitment.
tional activation of p15INK4b (cdkn2b) and p21CIP1/WAF1
(cdkn1a), whereas Myc can bind NF-Y and repress Max Is Essential for Gene Repression by Myc
pdgf- receptor [2, 6, 7, 19]. However, it remains unclear To evaluate if heterodimerization by Myc and Max was
essential for gene repression, we assessed gene regula-how target gene specificity is achieved for Myc repres-
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Myc (Myc, Myc and Max, and Myc and MaxEG) re-
pressed expression of the genes compared to cells in-
fected with control retrovirus; this repression presum-
ably occurred through interaction with endogenous Max
protein (Figure 4B). By contrast, constitutive expression
of Max, MaxEG, MycEG, or MycEG and Max was insuffi-
cient to trigger repression (Figure 4B). Importantly, cells
that coexpressed MycEG and MaxEG showed repres-
sion of gene expression, which was comparable to wild-
type Myc alone (Figure 4B). Thus, Myc repression of gene
transcription requires a functional Myc:Max complex.
Conclusions
The data shows that Myc bound target genes can be
efficiently identified by combining ChIP and CpG island
microarrays. Subsequent analyses of known and novel
Myc targets showed that Myc and Max were cobound
at all loci tested, which included 14 repressed genes.
Further analysis of this association shows that Max was
bound to repressed regulatory regions prior to Myc’s
recruitment and that interaction between Myc and Max
was essential for Myc to repress gene transcription.
Taken together, we propose that the Myc:Max hetero-
dimer is required for Myc-dependent transcriptional ac-
Figure 4. Max Can Bind to Genes Independently of Myc, and the
tivation and repression, which leads to Myc-directedMyc:Max Interaction Is Essential for Myc to Repress Gene Ex-
activities, including transformation.pression
(A) ChIP assays with anti-c-Myc (lanes 1 and 5), anti-Max (lanes 9
Supplemental Dataand 13), or no antibody (lanes 2, 6, 10, and 14) in Rat1c-myc/ cells
Supplemental Data including the list of human genomic loci boundinfected with an ecotropic retrovirus carrying c-myc or empty vector.
by Myc are available at http://images.cellpress.com/supmat/Additional control reactions include 1 input chromatin (lanes 3, 7,
supmatin.htm.11, and 15) and a no template mock IP (lane 4, 8, 12, and 16). DNA
was PCR amplified by using primers against Myc-activated (cad)
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